WINT(Delisted)
WindtreeยทNASDAQ
--
--(--)
WINT Profile
Windtree Therapeutics, Inc.
A biotech company focused on advancing multiple late-stage interventions for acute cardiovascular disorders
2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976-3622
--
Windtree Therapeutics, Inc., was founded in Delaware in 1992. The company is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. The company's product portfolio includes istaroxime, a Phase 2 drug candidate with sarcoplasmic reticulum Ca 2 + -ATPase 2 a or SERCA 2 a that activates the properties of acute heart failure and related cardiogenic shock, preclinical SERCA 2 a activator for heart failure, rostafuroxin for the treatment of hypertension in patients with specific genetic profiles, And a preclinical atypical protein kinase C iota, or aPKCI, an inhibitor (topical and oral formulation), is being developed for potential applications in rare and broad tumor indications.
